Changing the Way Radiologists Performance is Assessed with the help of Machine Learning and Natural Language Processing Radiologists quality evaluation programs are highly variable and rarely lead to improved patient care. Some organizations like the American College of Radiology have substantially elevated the topic by creating frameworks and data repositories to collect information on radiologists […]

In the first three parts of this series, I made the case for electronic health records, addressed their problems, and then talked about the need to build structures to share this data with one another to improve care and lower costs. I believe we are on the cusp new technologies for medical screening with recent

Lung cancer is unrelenting – especially for those who present late in the disease process. Every year more people die of lung cancer than breast, colon and prostate cancer combined according to data from the American Cancer Society. In my hometown of Chattanooga, Cancer is the most common cause of death, even above heart disease.

In Part 2 of this series, I talked about the shortcomings of Electronic Health Records (EHRs). Most small medical practices do not have the resources to mine the data within their Electronic Health Records (EHRs). A 2016 report from the U.S. Department of Health and Human Services’ Centers for Disease Control and Prevention (CDC) found

In Part 1 of this series, I spoke about the benefits of Electronic Health Records (EHRs). But they do not come without problems. One of my goals as a physician is to understand the needs of the individual patient and the specific population that we serve. Yes, Electronic Health Records (EHRs) help, but they alone

As a physician, I was trained to listen to, examine, diagnose and design a treatment plan for one individual patient at a time. That was the focus of my education, and I considered it my highest calling. I still do. However, as a leader in a healthcare system, while I still consider this absolutely necessary,

Lung cancer screening rates remain extremely low. In 2015, less than 4 percent of people eligible for lung cancer screening received it,according to a 2017 study published in JAMA Oncology and cited by the American Cancer Society. So how can providers discern the truly useful solutions? If you know the right features to look for,